HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards
October 24 2024 - 8:31AM
Business Wire
Company Receives Top Honors in the ‘Home Health
Diagnostic’ Category for its Groundbreaking Technology that
Captures the Heart’s Electrical Signals from Three Dimensions
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology
company focused on transforming cardiac care by providing powerful
cardiac insights wherever the patient is, announced today its
selection as a winner of the 2024 Digital Health Hub Awards, hosted
by The Digital Health Hub Foundation. Chief Executive Officer Rob
Eno accepted the Rising Star award in the ‘Home Health Diagnostic’
category during the renowned HLTH global healthcare conference.
“One of the main challenges in cardiac care is helping patients
get the care they need in a timelier manner to prevent worse
outcomes or an increased risk of death. This award is a validation
of our dedicated team’s hard work to deliver a simple way for
patients to capture high-fidelity ECG signals wherever they are
when symptoms occur to minimize any delays in care,” commented Mr.
Eno.
The recognition highlights HeartBeam’s use of cutting-edge
digital innovations to achieve its mission of unlocking a more
personalized approach to cardiac care. HeartBeam’s groundbreaking
vector-based technology captures the heart’s electrical signals
from three dimensions to provide total heart intelligence. By
leveraging AI to analyze the data-rich signals, the Company
believes it will be able to unlock a more personalized approach to
cardiac care for patients.
The Company’s first application of its vector-based technology
is a cable-free, credit card-sized device that is designed to be
capable of synthesizing a 12-lead ECG. The HeartBeam system is
currently under review with the FDA. The Company has 13 issued US
patents and 4 issued international patents supporting the
underlying technology.
"The competition this year has been extraordinary, with
thousands of submissions from groundbreaking companies worldwide,”
said Mark H. Goldstein, Chairman and Founder of The Digital Health
Hub Foundation. “We congratulate our winners whose innovations have
truly impressed our esteemed panel of judges. The Digital Health
Hub Foundation looks forward to witnessing the profound impact our
champions continue to make in the healthcare space.”
The Digital Health Hub Foundation’s mission is to support the
world’s most innovative healthcare companies in scaling and
growing. Since 2017, the 30,000-member community has been dedicated
to fostering innovation, including early-to-late-stage healthcare
companies, industry providers, payors, mentors, and investors. The
annual awards bring together the healthcare industry to celebrate
and validate the best of the best in health technology.
About HeartBeam, Inc.
HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company
dedicated to transforming cardiac care by providing powerful
cardiac insights wherever the patient is. The Company is creating
the first ever cable-free 12-lead ECG capable of capturing the
heart’s electrical signals from three dimensions. This platform
technology is designed to be used in portable devices that can be
used wherever the patient is to deliver actionable heart
intelligence. Physicians will be able to identify cardiac health
trends and acute conditions and direct patients to the appropriate
care – all outside of a medical facility, thus redefining the
future of cardiac health management. The Company holds 13 US and 4
international issued patents related to technology enablement.
For additional information, visit HeartBeam.com.
Forward-Looking Statements
All statements in this release that are not based on historical
fact are "forward-looking statements." While management has based
any forward-looking statements included in this release on its
current expectations, the information on which such expectations
were based may change. Forward-looking statements involve inherent
risks and uncertainties which could cause actual results to differ
materially from those in the forward-looking statements, as a
result of various factors including those risks and uncertainties
described in the Risk Factors and in Management’s Discussion and
Analysis of Financial Condition and Results of Operations sections
of our Forms 10-K, 10-Q and other reports filed with the SEC and
available at www.sec.gov. We urge you to consider those risks and
uncertainties in evaluating our forward-looking statements. We
caution readers not to place undue reliance upon any such
forward-looking statements, which speak only as of the date made.
Except as otherwise required by the federal securities laws, we
disclaim any obligation or undertaking to publicly release any
updates or revisions to any forward-looking statement contained
herein (or elsewhere) to reflect any change in our expectations
with regard thereto or any change in events, conditions or
circumstances on which any such statement is based.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241024303708/en/
Investor Relations Contact: Chris Tyson Executive Vice
President MZ North America Direct: 949-491-8235 BEAT@mzgroup.us
www.mzgroup.us Media Contact:media@heartbeam.com
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Nov 2024 to Dec 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Dec 2023 to Dec 2024